Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

US Stocks Lower; Dow Falls Over 50 Points

Published 27/11/2023, 14:46
Updated 27/11/2023, 16:10
© Reuters.  US Stocks Lower; Dow Falls Over 50 Points

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday.

Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13% to 14,231.78. The S&P 500 also fell, dropping, 0.25% to 4,548.14.

Check This Out: IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying

Leading and Lagging Sectors

Communication services shares edged higher on Monday.

In trading on Monday, energy shares fell by 0.7%.

Top Headline

Shopify Inc (NYSE: SHOP) merchants accomplished a record-breaking $4.1 billion in sales on Black Friday, marking a 22% increase from the previous year.

Sales peaked when collective sales reached $4.2 million per minute at 12:01 p.m. EST.

Equities Trading UP

RedHill Biopharma Ltd. (NASDAQ: RDHL) shares shot up 130% to $0.7241 after the company announced the FDA has granted five years' market exclusivity for Talicia.

Shares of Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) got a boost, shooting 75% to $4.69 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.

Tharimmune, Inc. (NASDAQ: THAR) shares were also up, gaining 53% to $4.41 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.

Equities Trading DOWN

BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares dropped 21% to $0.71 after jumping 144% on Friday.

Shares of Impel Pharmaceuticals Inc. (NASDAQ: IMPL) were down 14% to $0.73 after gaining 8% on Friday. Impel Pharmaceuticals recently announced exploration of strategic alternatives.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ProQR Therapeutics N.V. (NASDAQ: PRQR) was down, falling 18% to $1.21.

Also Check This Out: Top 5 Consumer Stocks That Are Preparing To Pump This Quarter

Commodities

In commodity news, oil traded down 0.3% to $75.34 while gold traded up 0.5% at $2,012.40.

Silver traded up 2% to $24.82 on Monday while copper fell 0.8% to $3.7595.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, London’s FTSE 100 fell 0.2% while Spain’s IBEX 35 Index rose 0.3% The German DAX fell 0.2% French CAC 40 slipped 0.1%, while Italy’s FTSE MIB Index rose 0.1%.

Asia Pacific Markets

Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 0.53%, Hong Kong’s Hang Seng Index falling 0.20% and China’s Shanghai Composite Index falling 0.30%. India’s S&P BSE Sensex, meanwhile, fell 0.1%.

Hong Kong’s trade deficit increased to $25.8 billion in October from $20.9 billion in the year-ago month. Profits earned by Chinese industrial firms fell by 7.8% year-over-year to CNY 6,115.42 billion in the first ten months of 2023, compared to a 9.0 % decline in the previous period.

Economics

Data on new home sales will be released at 10:00 a.m. ET.

Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.